# A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer

Source: https://onco.cc/trials/nct06202261/  
OnCo record `nct06202261` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of TQB2930, TQB3616, Fulvestrant, Capecitabine, Vinorelbine and Eribulin in advanced solid tumours, run by Chia Tai Tianqing Pharmaceutical Group Co., Ltd., now recruiting.

## Summary

A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer is a phase 1/2 interventional study registered as NCT06202261 by Chia Tai Tianqing Pharmaceutical Group Co., Ltd., with 154 participants planned, started 2023-04-13 and due to reach its primary completion in 2026-12. Interventions recorded: TQB2930 for injection, Paclitaxel for injection (albumin-bound), TQB3616 capsule, Fulvestrant injection, Capecitabine tablets and Vinorelbine tartrate injection.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06202261
- Phase: 1/2
- Setting: A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of TQB2930 for Injection Monotherapy or in Combination for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Recurrent / Metastatic Breast Cancer
- Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Enrolled: 154

## Sources

- ClinicalTrials.gov NCT06202261: https://clinicaltrials.gov/study/NCT06202261

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)
- drugs: [Capecitabine](https://onco.cc/drugs/capecitabine/), [Eribulin](https://onco.cc/drugs/eribulin/), [Fulvestrant](https://onco.cc/drugs/fulvestrant/), [TQB2930](https://onco.cc/drugs/tqb2930/), [TQB3616](https://onco.cc/drugs/tqb3616/), [Vinorelbine](https://onco.cc/drugs/vinorelbine/)
- companies: [Sino Biopharmaceutical (Chia Tai Tianqing)](https://onco.cc/companies/sino-biopharm/)

---
JSON: https://onco.cc/api/v1/entities/nct06202261.json